Profil
Christine R.
Coyne currently works at Iterum Therapeutics Plc, as Chief Commercial Officer from 2025.
Ms. Coyne also formerly worked at SCYNEXIS, Inc., as Chief Commercial Officer from 2021 to 2022 and Paratek Pharmaceuticals, Inc., as Senior Vice President-Commercial from 2020 to 2021.
Ms. Coyne received her Masters Business Admin degree from Eastern University and undergraduate degree from West Chester University of Pennsylvania.
Postes actifs de Christine Coyne
| Sociétés | Poste | Début |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 30/06/2025 |
Anciens postes connus de Christine Coyne
| Sociétés | Poste | Fin |
|---|---|---|
| SCYNEXIS, INC. | Corporate Officer/Principal | 30/11/2022 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2021 |
Formation de Christine Coyne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Eastern University
Eastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Chester University of Pennsylvania
West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Iterum Therapeutics Plc
Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
















